fundvisualizer.com

iShares Micro-Cap ETFIWC

Performance (before sales charge)

As of 08/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 08/31/2022
Stock
98.32%
Non-U.S. Stock
1.57%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.11%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 08/31/2022

Basic materials

3.24%

Consumer cyclical

9.99%

Financial services

19.04%

Real estate

5.67%

Consumer defensive

2.50%

Health care

29.05%

Utilities

0.91%

Communication services

2.33%

Energy

4.79%

Industrials

10.91%

Technology

11.46%

Top 10 holdings

As of 08/31/2022

ChemoCentryx Inc
0.71%
Impinj Inc
0.42%
Prometheus Biosciences Inc
0.34%
International Seaways Inc
0.32%
Uranium Energy Corp
0.32%
Verve Therapeutics Inc
0.31%
Celldex Therapeutics Inc
0.31%
Meridian Bioscience Inc
0.31%
TransMedics Group Inc
0.31%
Dynavax Technologies Corp
0.30%
Fund assets

$941.82 Million

Share class

--

Morningstar category

Small Blend

Expense ratio

0.60%

Investment objective

Growth

Documents